Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients Ruchika Sharma4 May 2025 12:30 PM ISTBerlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha...
Bayer appoints Guru Ramamurthy as new CFO for Crop Science division Ruchika Sharma29 April 2025 12:25 PM ISTMonheim: Bayer has announced that Guru Ramamurthy will become the new Chief Financial Officer (CFO) for Bayer's Crop Science division. He will...
Bayer seeks EMA approval for Aflibercept for retinal vein occlusion treatment Ruchika Sharma9 April 2025 1:41 PM ISTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution...
Bayer arm AskBio elects Independent Director Dr Laura Sepp Lorenzino to Board Ruchika Sharma9 April 2025 11:30 AM ISTResearch Triangle Park: AskBio Inc., a gene therapy company wholly owned and independently operated subsidiary of Bayer AG, has announced...
Bayer eyes launch of heart, menopause relief drugs in 2025 Ruchika Sharma8 April 2025 12:30 PM ISTLondon: Bayer said it is gearing up to launch two new pharmaceutical products this year, each with the potential to generate more than $1 billion in...
Bayer Takes Roundup Cancer Case Back to Supreme Court Farhat Nasim5 April 2025 10:45 AM ISTBayer has warned U.S. lawmakers it might halt Roundup sales to farmers, unless they can strengthen legal protection against the litigation.
Bayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced solid tumors treatment Ruchika Sharma4 April 2025 10:30 AM ISTSan Diego: Vividion Therapeutics, Inc. has announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, an...
Bayer, Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor Ruchika Sharma27 March 2025 9:15 AM ISTBerlin: Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, have announced that they have entered into a global...
Dr Mike Graham to become new Head of RnD for Bayer Crop Science division Ruchika Sharma25 March 2025 11:15 AM ISTMonheim: Bayer has announced that Dr Mike Graham will become the new Head of Research & Development (R&D) for Bayer’s Crop Science...
Bayer Finerenone secures USFDA Priority Review designation for heart failure Ruchika Sharma17 March 2025 4:30 PM ISTBerlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug Administration (FDA) for finerenone...
Bayer arm advances Gene therapy clinical trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 Ruchika Sharma9 March 2025 10:30 AM ISTResearch Triangle Park: AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has announced...
Bayer begins Phase II trial with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumors Ruchika Sharma5 March 2025 9:00 AM ISTBerlin: Bayer has announced that the first patient has been enrolled in the global Phase II panSOHO study, an open-label clinical trial,...
